Drug Testing: Technologies and Global Markets
Report Highlights
The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.
Report Includes
- An overview of the global market for drug testing technologies.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
- Information on leading players in the market and their key products.
- Analysis of leading companies in the field and their successful strategies.
Report Scope
This report contains:
- An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
- Drug abuse statistics in key regions.
- Analysis of regulatory environments in North, South and Central America, Europe, and Asia-Pacific, and country-wise summaries of national legislation and policies.
- Drug of abuse testing markets with respect to testing approaches and sample matrices.
- Technology trends in the drug of abuse testing market.
- Leading players in the market and their key products.
- Sales projections through 2022 for drug of abuse testing markets by sample matrix and geographic regions.
- Analysis of leading companies and their successful strategies.
Analyst Credentials
JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.
Report Highlights
The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.
Report Includes
- An overview of the global market for drug testing technologies.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
- Information on leading players in the market and their key products.
- Analysis of leading companies in the field and their successful strategies.
Report Highlights
- The global market for DOA testing increased from $1.9 billion in 2007 to an estimated $2.0 billion by the end of 2008. It should reach $2.6 billion in 2014, for a compound annual growth rate (CAGR) of 4.6%.
- The U.S. testing market segment generated the largest share of revenues with $1.4 billion in 2007. This is expected to reach $1.5 billion in 2008 and $2.0 billion in 2014, for a CAGR of 5.2%.
- The European Union had the second largest market segment with $365.2 million in sales in 2007. This is expected to grow at a CAGR of 2.9% to reach $374.2 million in 2008 and $445.9 million in 2014.
Report Highlights
- Drugs of abuse testing sales will reach $1.6 billion in 2007, rising at an AAGR (average annual growth rate) of 4.7%.
- Sales in the U.S. are expected to reach $996 million in 2002 and forecasted to grow to $1.3 billion in 2007 at an AAGR of 5.4%.
- Sales in Europe expected to be $291 million in 2002 and forecasted to grow at an AAGR of 1.8% to approximately $318 million in 2007.
- The number of different places and applications, such as a workplace, drug court, hospital, and school, for drug testing, with blood, hair, oral fluid, sweat or urine samples, reflects the need for a variety of drug testing services and the versatility of drug testing technology.